Patients and those with affected family or community members have joined researchers, clinicians, and experts in their efforts to unlock the mysteries of Long COVID....
Decentralized clinical trials rose in prominence during the COVID-19 pandemic. Are they here to stay?...
Scientists have unveiled a road map for the development of a new vaccine that would be broadly protective against all coronaviruses....
National Institutes of Health (NIH) representatives state that international investment, collaboration, and coordination have been key to responding to the COVID-19 pandemic....
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
SMPH faculty members share their experiences related to the novel coronavirus and its ramifications on individuals, families and communities....
The lasting impacts of the COVID-19 pandemic will be felt for decades to come, and some of those impacts aren’t fully understood yet, especially among communities of color and the elderly....
According to GlobalData’s Clinical Trial Database, six out of the 11 planned trials disclosed in the last two weeks will be investigating Covid-19 boosters and therapeutics....
How technology can enable clinical trials participation, leading to lower participant burden and better data....
